Orak hücre anemili çocuklarda, hasta kontrollü analjezi yönteminin etkinliğini, kullanıcıların değerlendirmesi

Amaç: Orak hücreli anemi (OHA) tanılı çocukların ağrılı krizlerinde, hasta kontrollü analjezi (HKA) yöntemi ağrı tedavisinde tercih edilen bir yöntemdir. Bu çalışma ile OHA tanılı çocuklarda iv HKA yöntemini uygulayan sağlık personeli ve ebevenlerin, yöntem hakkındaki düşüncelerinin ve ilaç uygulama tutumlarının değerlendirilmesi amaçlandı.Gereç ve Yöntem: Algoloji Bilim Dalı tarafından iv HKA yöntemi uygulanan OHA tanılı çocuk hastaların ebeveynleri (n=54) ve tedavileri ile ilgilenen sağlık personelleri (doktor, hemşire) (n=32) olmak üzere toplam 86 kişi çalışmaya alındı. Yöntemin etkinliğinin değerlendirilmesi için katılımcılara anket uygulandı. Kullanıcıların HKA yöntemi hakkındaki bilgi düzeyleri, avantaj ve dezavantajları hakkındaki görüşleri sorgulandı. Bulgular: Sağlık personellerinin %65.6'sı (n=21) HKA yönteminin "akut dönemde gerekli" olduğunu düşündüğü saptandı. Ağrının gece ve gündüz daha iyi kontrol edildiğini düşünenlerin oranı %93 (n=80) idi. Ebeveynlerin %83.3'ü (n=45) sağlık personelinin %87.5'i (n=28) yöntemin ilaca ulaşamama korkusunu azalttığını belirtmiş idi. Ağrının yeniden başlama korkusundaki azalma sağlık personeline göre ebeveynlerde daha belirgindi (sırasıyla %37, %9.4) (p

Evaluation of the effectiveness of patient-controlled analgesia in children with sickle cell anemia from the perspective of healthcare professionals and parents

Objectives: This study evaluated the efficacy of patient-controlled analgesia (PCA) used by children with sickle cell anemia (SCA) based on the attitudes of parents and healthcare professionals.Methods: A total of 86 individuals were involved in the study: 54 parents of children with SCA who were receiving treatment and 32 healthcare providers (doctors, nurses). To evaluate the effectiveness of the PCA method, a questionnaire was prepared to determine the level of knowledge of the participants about the PCA method and their perception of its advantages and disadvantages.Results: According to 65.6% (n=21) of the healthcare providers, PCA should be used during acute phase of pain. The great majority of the participants (93%; n=80) thought that pain was effectively controlled both during the day and at night. PCA reduced the fear of unavailability of analgesic drugs in 83.3% (n=45) of parents and in 87.5% (n=28) of healthcare providers. More parents (37%) reported a reduction in the fear of return of pain than healthcare providers (9.4%) (p<0.05). Most parents (87%; n=47) reported that they preferred to wait until their child complained of severe pain to use on-demand doses of analgesic due to concerns about overdose and addiction. Resolving machine alarms (48%; n=26) and the length of time required to refill the machine (48%; n=26) were reported as disadvantages of PCA method.Conclusion: In this study, parents and healthcare professionals found PCA to be effective in relieving pain in children with SCA; however, fears and biased knowledge of users about the analgesic drug are thought to inhibit reaching sufficient dosage. Educational courses for users about PCA and the drugs used may increase the effectiveness of PCA method.

PDF

___

Dampier CD, Smith WR, Wager CG, Kim HY, Bell MC, Miller ST, et al. IMPROVE trial: a randomized controlled trial of pa- tient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recom- mendations for future studies. Clin Trials 2013;10(2):319- 31.
Jacob E, Mueller BU. Pain experience of children with sickle cell disease who had prolonged hospitalizations for acute painful episodes. Pain Med 2008;9(1):13-21.
Melzer-Lange MD, Walsh-Kelly CM, Lea G, Hillery CA, Scott JP. Patient-controlled analgesia for sickle cell pain crisis in a pediatric emergency department. Pediatr Emerg Care 2004;20(1):2-4.
Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J. Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol 2003;120(5):744-52.
van Beers EJ, van Tuijn CF, Nieuwkerk PT, Friederich PW, Vranken JH, Biemond BJ. Patient-controlled analgesia ver- sus continuous infusion of morphine during vaso-occlu- sive crisis in sickle cell disease, a randomized controlled trial. Am J Hematol 2007;82(11):955-60.
Johnson L. Sickle cell disease patients and patient-con- trolled analgesia. Br J Nurs 2003;12(3):144-53.
Yücel A. Hasta kontrollü analjezi (Patient Controlled Anal- gesia) PCA. 1. baskı. İstanbul: Ufuk R&M; 1997.
Viscusi ER. Patient-controlled drug delivery for acute post- operative pain management: a review of current and emer- ing technologies. Reg Anesth Pain Med 2008;33:146-8.
Yarkan Uysal H, Acar HV, Kaya A, Ceyhan A. A retrospective investigation of the patient-controlled analgesia methods applied for postoperative pain management. Experimen- tal Investigations 2013;4(2):159-65.
Gülücü C, Aşık İ. Hasta kontrollü analjezi yöntemleri. İçinde: Özatamer O, Batislam Y, Özgencil GE, Alkaya F, editör- ler. Anestezide güncel konular II. 6. baskı İstanbul: Nobel; 2010. s. 457-76.
Anghelescu DL, Faughnan LG, Oakes LL, Windsor KB, Pei D, Burgoyne LL. Parent-controlled PCA for pain management in pediatric oncology: is it safe? J Pediatr Hematol Oncol 2012;34(6):416-20.
Platt DS, Thorington BD, Brambilla DJ, Millner PF, Rosse WF, Vichinsky E, et al. Pain in sickle cell disease ratio and risk factors. N Engl J Med 1991:325;1-6.
Dampier CD, Setty BN, Logan J, Ioli JG, Dean R. Intravenous morphine pharmacokinetics in pediatric patients with sickle cell disease. J Pediatr 1995;126:461-7.
Jacobson SJ, Kopecky EA, Joshi P, Babul N. Randomised trial of oral morphine for painful episodes of sickle-cell dis- ease in children. Lancet 1997;350(9088):1358-61.
Berde CB, Lehn BN, Yee YD. Patient controlled analgesia in children and adolescents: a randomised prospective com- parison with intramuscular morphine for postoperative analgesia. Pediatrics 1993;118:460-6.
Asford H. Sickle cell disease: patient controlled analgesia for paediatric patient in a vaso-oclusive crisis. The Plym- outh Student Journal of Health & Social Work 2011;3:1-12.
Beyer JE. Judging the effectiveness of analgesia for chil- dren and adolescents during vaso-occlusive events of sickle cell disease. J Pain Symptom Manage 2000;19:63-72.
Chambers CT, Reid GJ, McGrath PJ, Finley GA. Develop- ment and preliminary validation of a postoperative pain measure for parents. Pain 1996;68(2-3):307-13.
Lewis ET, Combs A, Trafton JA. Reasons for under-use of prescribed opioid medications by patients in pain. Pain Med 2010;11(6):861-71.